DTx is an early stage SD-based JLABS company developing a novel ‘enabling’ technology for the efficient delivery of nucleic acid drugs to tissues throughout the body. Founded only 8 months ago, DTx has quickly produced and tested proprietary modifications of siRNA utilizing lipid conjugates with dramatic activity in vivo and in vitro.
